Corcept Therapeutics (CORT) Short Interest Ratio & Short Volume $72.05 +0.05 (+0.07%) As of 09:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Corcept Therapeutics Short Interest DataCorcept Therapeutics (CORT) has a short interest of 11.05 million shares, representing 11.85% of the float (the number of shares available for trading by the public). This marks a -1.52% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.6, indicating that it would take 8.6 days of the average trading volume of 1.33 million shares to cover all short positions.Current Short Interest11,050,000 sharesPrevious Short Interest11,220,000 sharesChange Vs. Previous Month-1.52%Dollar Volume Sold Short$742.23 millionShort Interest Ratio8.6 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares105,370,000 sharesFloat Size93,240,000 sharesShort Percent of Float11.85%Today's Trading Volume18,507 sharesAverage Trading Volume1,334,707 sharesToday's Volume Vs. Average1% Short Selling Corcept Therapeutics? Sign up to receive the latest short interest report for Corcept Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCORT Short Interest Over TimeCORT Days to Cover Over TimeCORT Percentage of Float Shorted Over Time Corcept Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202511,050,000 shares $742.23 million -1.5%11.9%8.6 $67.17 7/15/202511,220,000 shares $801.22 million -2.0%12.0%8.3 $71.41 6/30/202511,450,000 shares $840.43 million -9.5%12.2%7.6 $73.40 6/15/202512,650,000 shares $886.26 million +0.1%13.5%7.6 $70.06 5/31/202512,640,000 shares $987.06 million +1.3%13.5%7.6 $78.09 5/15/202512,480,000 shares $915.53 million -5.3%13.3%7.7 $73.36 4/30/202513,180,000 shares $947.38 million +7.2%14.1%8.2 $71.88 4/15/202512,290,000 shares $855.26 million -25.7%13.2%7.9 $69.59 3/31/202516,530,000 shares $1.89 billion +1.2%17.7%11.5 $114.22 3/15/202516,330,000 shares $914.64 million +1.8%17.5%16.2 $56.01 Get the Latest News and Ratings for CORT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/202516,040,000 shares $971.70 million +4.2%17.2%16.2 $60.58 2/15/202515,390,000 shares $1.12 billion -2.7%16.7%17.5 $72.72 1/31/202515,810,000 shares $1.06 billion -2.8%17.6%18.2 $66.92 1/15/202516,260,000 shares $874.46 million +1.9%18.0%17.6 $53.78 12/31/202415,960,000 shares $804.22 million +1.5%17.7%16.7 $50.39 12/15/202415,720,000 shares $870.89 million -7.8%17.4%15.9 $55.40 11/30/202417,050,000 shares $983.44 million -7.0%18.9%17.1 $57.68 11/15/202418,340,000 shares $950.56 million -2.5%20.3%18.8 $51.83 10/31/202418,800,000 shares $920.64 million -9.1%20.8%20.7 $48.97 10/15/202420,680,000 shares $968.65 million -3.9%23.0%22.8 $46.84 9/30/202421,510,000 shares $995.48 million -0.9%23.9%25.4 $46.28 9/15/202421,710,000 shares $827.37 million -1.7%24.1%25.4 $38.11 8/31/202422,090,000 shares $779.78 million +2.3%24.6%24.5 $35.30 8/15/202421,590,000 shares $754.35 million -3.0%24.0%21.2 $34.94 7/31/202422,260,000 shares $860.79 million -2.2%24.8%20.2 $38.67 7/15/202422,750,000 shares $735.96 million +4.0%25.3%19.6 $32.35 6/30/202421,880,000 shares $710.88 million +3.0%24.4%19 $32.49 6/15/202421,250,000 shares $615.61 million +10.2%23.7%18.6 $28.97 5/31/202419,290,000 shares $581.98 million -2.6%21.5%17.9 $30.17 5/15/202419,800,000 shares $551.03 million No Change22.1%19.4 $27.83 4/30/202419,800,000 shares $461.74 million -6.3%22.1%18 $23.32 4/15/202421,120,000 shares $488.93 million -1.0%23.7%17.5 $23.15 3/31/202421,330,000 shares $537.30 million +5.5%23.9%15 $25.19 3/15/202420,220,000 shares $469.71 million +1.8%22.7%13 $23.23 2/29/202419,860,000 shares $466.71 million +1.1%22.3%13.1 $23.50 2/15/202419,640,000 shares $480.39 million +1.7%22.0%13.4 $24.46 1/31/202419,320,000 shares $407.65 million +23.3%22.0%14.4 $21.10 1/15/202415,670,000 shares $363.54 million +1.8%17.8%13.2 $23.20 12/31/202315,390,000 shares $499.87 million +0.9%17.5%17 $32.48 12/15/202315,260,000 shares $453.99 million -0.8%17.4%19.6 $29.75One stock to replace Nvidia (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here. 11/30/202315,380,000 shares $391.73 million +0.7%17.5%21.2 $25.47 11/15/202315,270,000 shares $387.55 million +8.1%17.4%20.6 $25.38 10/31/202314,120,000 shares $396.49 million -5.6%16.1%19.4 $28.08 10/15/202314,960,000 shares $412.30 million -0.1%17.1%20 $27.56 9/30/202314,970,000 shares $407.86 million +3.4%17.1%20.8 $27.25 9/15/202314,480,000 shares $484.65 million -2.2%16.6%24.1 $33.47 8/31/202314,800,000 shares $484.40 million -0.5%17.0%23.7 $32.73 8/15/202314,870,000 shares $460.38 million -1.3%17.1%23.9 $30.96 7/31/202315,070,000 shares $383.98 million -4.2%17.3%23.9 $25.48 7/15/202315,730,000 shares $358.96 million -1.1%18.2%27.3 $22.82 6/30/202315,910,000 shares $354.00 million -5.1%18.4%25.2 $22.25 6/15/202316,770,000 shares $388.90 million +0.2%19.2%21.6 $23.19 5/31/202316,730,000 shares $392.99 million -2.3%19.2%20.9 $23.49 5/15/202317,130,000 shares $412.15 million No Change19.6%19.2 $24.06 10/31/202217,050,000 shares $487.63 million -0.8%18.3%30.1 $28.60 10/15/202217,190,000 shares $467.91 million -0.8%18.6%30.8 $27.22 9/30/202217,330,000 shares $444.34 million +1.5%18.7%29.7 $25.64 9/15/202217,070,000 shares $431.87 million -1.6%18.5%26.7 $25.30 8/31/202217,350,000 shares $447.98 million -1.0%18.8%27 $25.82 8/15/202217,530,000 shares $492.07 million -2.2%19.0%25.6 $28.07 7/31/202217,930,000 shares $513.87 million +1.1%19.0%22.4 $28.66 7/15/202217,730,000 shares $482.97 million -1.8%18.8%21.5 $27.24 6/30/202218,060,000 shares $429.47 million -0.6%17.5%20.5 $23.78 6/15/202218,170,000 shares $383.39 million -5.6%17.6%19.8 $21.10 5/31/202219,240,000 shares $400.96 million -5.2%20.4%20.1 $20.84 5/15/202220,300,000 shares $384.48 million +12.0%21.5%20.6 $18.94 4/30/202218,130,000 shares $389.98 million +9.5%19.2%18.7 $21.51 4/15/202216,560,000 shares $405.55 million +2.8%17.6%17.5 $24.49 3/31/202216,110,000 shares $362.80 million -2.8%N/A18 $22.52 3/15/202216,570,000 shares $397.68 million +2.3%17.6%16.7 $24.00 2/28/202216,200,000 shares $361.10 million -0.9%17.1%9.6 $22.29 2/15/202216,340,000 shares $331.87 million -10.2%17.2%9.5 $20.31 1/31/202218,190,000 shares $341.43 million -5.2%17.6%10.5 $18.77 1/15/202219,180,000 shares $353.87 million +13.3%18.5%11.3 $18.45 12/31/202116,930,000 shares $335.21 million -12.9%16.3%10.2 $19.80 12/15/202119,440,000 shares $375.19 million +116.0%18.8%12.5 $19.30 11/30/20219,000,000 shares $189 million +0.5%8.7%9.8 $21.00 11/15/20218,960,000 shares $205.09 million -2.9%8.7%14.8 $22.89 10/29/20219,230,000 shares $166.14 million +9.9%8.9%17.9 $18.00 10/15/20218,400,000 shares $168.34 million -0.7%8.1%17.2 $20.04 9/30/20218,460,000 shares $166.49 million +0.8%8.1%17.5 $19.68 9/15/20218,390,000 shares $171.41 million +1.0%8.1%17 $20.43 8/31/20218,310,000 shares $176.84 million +3.1%8.0%15.8 $21.28 8/13/20218,060,000 shares $166.68 million +2.3%7.7%15.2 $20.68 7/30/20217,880,000 shares $163.67 million +3.1%7.6%13.3 $20.77 7/15/20217,640,000 shares $155.55 million -5.2%7.3%13.6 $20.36 6/30/20218,060,000 shares $177.32 million -18.5%7.7%14.4 $22.00 6/15/20219,890,000 shares $216.89 million -2.9%9.4%17.8 $21.93 5/28/202110,180,000 shares $219.89 million +3.0%9.7%19.9 $21.60 5/14/20219,880,000 shares $206.69 million -1.7%9.4%17.7 $20.92One stock to replace Nvidia (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here. 4/30/202110,050,000 shares $235.77 million -5.4%9.6%17.5 $23.46 4/15/202110,620,000 shares $243.73 million +1.4%N/A0 $22.95 3/31/202110,470,000 shares $245.94 million -2.9%9.9%18 $23.49 3/15/202110,780,000 shares $276.94 million -0.2%10.2%17.6 $25.69 2/26/202110,800,000 shares $276.05 million No Change10.2%16.5 $25.56 2/12/202110,800,000 shares $309.64 million -4.7%10.3%13.6 $28.67 1/29/202111,330,000 shares $325.28 million -4.1%10.9%12.9 $28.71 1/15/202111,810,000 shares $326.19 million -0.7%11.3%12.9 $27.62 12/31/202011,890,000 shares $311.16 million -7.7%11.4%12.9 $26.17 12/15/202012,880,000 shares $330.37 million -6.1%12.3%13.5 $25.65 11/30/202013,720,000 shares $315.42 million -17.1%13.1%11.2 $22.99 11/15/202016,540,000 shares $299.21 million -5.7%15.8%5.7 $18.09 10/30/202017,530,000 shares $300.81 million -6.7%16.7%6.4 $17.16 10/15/202018,780,000 shares $345.18 million -1.4%18.0%6.6 $18.38 9/30/202019,040,000 shares $331.39 million +1.0%18.3%6.7 $17.41 9/15/202018,860,000 shares $334.20 million -18.6%18.1%6.5 $17.72 8/31/202023,160,000 shares $294.13 million +2.8%22.2%8.3 $12.70 CORT Short Interest - Frequently Asked Questions What is Corcept Therapeutics' current short interest? Short interest is the volume of Corcept Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 11,050,000 shares of CORT short. 11.85% of Corcept Therapeutics' shares are currently sold short. Learn More on Corcept Therapeutics' current short interest. What is a good short interest ratio for Corcept Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CORT shares currently have a short interest ratio of 9.0. Learn More on Corcept Therapeutics's short interest ratio. Which institutional investors are shorting Corcept Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corcept Therapeutics: Lighthouse Investment Partners LLC, Jane Street Group LLC, Caption Management LLC, Squarepoint Ops LLC, Diadema Partners LP, Intrinsic Edge Capital Management LLC, Walleye Capital LLC, Walleye Trading LLC, Twin Tree Management LP, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Corcept Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.85% of Corcept Therapeutics' floating shares are currently sold short. Is Corcept Therapeutics' short interest increasing or decreasing? Corcept Therapeutics saw a decrease in short interest during the month of July. As of July 31st, there was short interest totaling 11,050,000 shares, a decrease of 1.5% from the previous total of 11,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Corcept Therapeutics' float size? Corcept Therapeutics currently has issued a total of 105,370,000 shares. Some of Corcept Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corcept Therapeutics currently has a public float of 93,240,000 shares. How does Corcept Therapeutics' short interest compare to its competitors? 11.85% of Corcept Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Corcept Therapeutics: Annovis Bio, Inc. (14.19%), Royalty Pharma PLC (4.57%), Jazz Pharmaceuticals PLC (9.46%), Perrigo Company plc (4.17%), Supernus Pharmaceuticals, Inc. (9.93%), Pacira BioSciences, Inc. (13.25%), Nektar Therapeutics (6.11%), Omeros Corporation (23.76%), Assembly Biosciences, Inc. (0.73%), Cumberland Pharmaceuticals Inc. (0.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Corcept Therapeutics stock? Short selling CORT is an investing strategy that aims to generate trading profit from Corcept Therapeutics as its price is falling. CORT shares are trading down $0.80 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corcept Therapeutics? A short squeeze for Corcept Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CORT, which in turn drives the price of the stock up even further. How often is Corcept Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CORT, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Annovis Bio Short Squeeze Royalty Pharma Short Squeeze Jazz Pharmaceuticals Short Squeeze Perrigo Short Squeeze Supernus Pharmaceuticals Short Squeeze Pacira BioSciences Short Squeeze Nektar Therapeutics Short Squeeze Omeros Short Squeeze Assembly Biosciences Short Squeeze Cumberland Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CORT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access